Orally administered targeted recombinant Beta-lactamase prevents ampicillin-induced selective pressure on the gut microbiota: a novel approach to reducing antimicrobial resistance.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples